v3.19.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating activities    
Net loss for the year $ 10,556,601 $ 14,625,790
Adjustment for items not affecting cash    
Depreciation 69,212 89,026
Amortization 278,997 323,905
Interest expense 255,833 1,294,005
Share based compensation expense 1,347,399 1,540,580
Shares premium 0 1,249,994
Accretion expense 3,266,918 1,937,308
Fair Value Adjustment (337,923) 0
Gain/Loss on mark to market re-evaluation (2,048,697) 376,674
Allowance for doubtful accounts (19,694) (19,694)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities (7,744,556) (7,833,992)
Changes in non-cash working capital items    
Accounts receivable (1,290,769) 190,867
Prepaid expenses and other receivables (921,377) (205,608)
Due from related parties 312 (166)
Inventories (168,239) (9,194)
Accounts payable 424,179 (60,098)
Accrued liabilities 122,928 304,048
Customer advances 0 (120,762)
Deferred revenue 345,111 24,043
Net cash (used in) operating activities (9,232,411) (7,710,862)
Investing activities    
Acquisition of equipment (101,779) (21,567)
Net cash (used in) investing activities (101,779) (21,567)
Financing activities    
Proceeds on exercise of warrants 0 1,125,038
Proceeds from convertible loans 9,326,633 7,111,375
Repayment of Promissory notes principal 0 (200,000)
Repayment of Promissory notes interest 0 (49,505)
Repayment of Demand notes principal (50,000) (208,359)
Repayment of Demand notes interest (2,975) (79,259)
Proceeds from short-term loan 0 400,000
Repayment of short-term loan 0 (400,000)
Repayment of short-term loan interest 0 (3,200)
Net cash provided by financing activities 9,273,658 7,696,090
Net (decrease) in cash and cash equivalents for the year (60,532) (36,339)
Cash and cash equivalents, beginning of the year 507,311 543,650
Cash and cash equivalents, end of the year $ 446,779 $ 507,311

Source